{
    "nctId": "NCT03916068",
    "briefTitle": "Acute Post-Radiation Hyperbaric Oxygen (HBO2) for Breast Cancer Patients Who Have Recently Completed Radiation Therapy",
    "officialTitle": "A Pilot Study Comparing Acute Post-Radiation Hyperbaric Oxygen (HBO2) Versus Trental and Vitamin E for Breast Cancer Patients Who Have Recently Completed Radiation Therapy as Part of Their Treatment Course",
    "overallStatus": "TERMINATED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 1,
    "primaryOutcomeMeasure": "Change in breast fibrosis using Bakers Grade Assessment",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* \\> 18 years of age\n* Patient is currently undergoing treatment for breast cancer and is on one of two pathways:\n\n  * Pathway 1 involves lumpectomy with radiation therapy, recurrence years later, mastectomy and tissue expander with further radiation therapy\n  * Pathway 2 involves mastectomy and tissue expander, 6 weeks of radiation therapy, and an implant in 6 months\n* Undergone mastectomy with expander or implant reconstruction \\> 2 weeks before starting radiation therapy\n* Completed chest wall irradiation in the past 3 days\n* Willing to stop herbal medications as directed by provider\n* Willing to stop daily use of supplemental vitamin E (Multivitamin with vitamin E component is acceptable, vitamin E cream is also acceptable)\n* Willing to have photographs of chest area taken for research purposes only\n* Therapeutic PT-INR for participants taking Coumadin\n* If tissue expanders remain intact during radiation, plan for conversion to the final implants must occur \\> 4 months after completing radiation\n* Willing to travel to a Legacy Health facility for study related visits\n* Agree to attend study visits outside of standard of care visits, if needed\n* Willing to engage in pre/post testing and survey/phone calls\n* Willing to attend all 6 weeks of HBOT if randomized to that group\n\nExclusion Criteria:\n\n* \\< 18 years of age\n* Pregnant or lactating\n* Have final implant placed \\< 2 weeks before start of radiation therapy\n* Plan to place final impacts \\< 4 months from the completion of radiation therapy, if tissue expanders are intact during radiation therapy\n* Have evidence of ongoing infection or implant exposure before start of radiation therapy\n* Radiation completed more than 3 days prior to study start\n* Unable to comply with protocol\n* Unable to provide written informed consent\n* Unwilling or unable to stop oral supplemental Vitamin E\n* PT-INR outside of acceptable range for participants taking Coumadin\n* Any delay in radiation treatment greater than 14 days\n* Investigator does not believe study participation is in the best interest of the patient\n* History of a seizure within the last 5 years",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}